WO2012134170A3 - Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia - Google Patents

Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia Download PDF

Info

Publication number
WO2012134170A3
WO2012134170A3 PCT/KR2012/002279 KR2012002279W WO2012134170A3 WO 2012134170 A3 WO2012134170 A3 WO 2012134170A3 KR 2012002279 W KR2012002279 W KR 2012002279W WO 2012134170 A3 WO2012134170 A3 WO 2012134170A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
lung cancer
radix extract
cancer treatment
cosmetics containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/002279
Other languages
English (en)
Korean (ko)
Other versions
WO2012134170A2 (fr
Inventor
황성연
정경채
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Bio Medical Science Institute Co Ltd
Original Assignee
Korea Bio Medical Science Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Bio Medical Science Institute Co Ltd filed Critical Korea Bio Medical Science Institute Co Ltd
Publication of WO2012134170A2 publication Critical patent/WO2012134170A2/fr
Publication of WO2012134170A3 publication Critical patent/WO2012134170A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une nouvelle utilisation d'un extrait de racine de Rubia, et plus particulièrement, une composition pour le traitement du cancer du poumon et une composition pour des produits cosmétiques contenant, comme ingrédient actif, un extrait de racine de Rubia ayant d'excellents effets prophylactiques et thérapeutiques sur le cancer du poumon. L'extrait de racine de Rubia, selon la présente invention, élimine la prolifération des cellules cancéreuses dans le poumon et induit leur apoptose, et peut ainsi être utilisé efficacement dans la prophylaxie et le traitement du cancer du poumon.
PCT/KR2012/002279 2011-03-28 2012-03-28 Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia Ceased WO2012134170A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110027370A KR20120109142A (ko) 2011-03-28 2011-03-28 천초근 추출물을 포함하는 폐암 치료용 조성물 및 화장료 조성물
KR10-2011-0027370 2011-03-28

Publications (2)

Publication Number Publication Date
WO2012134170A2 WO2012134170A2 (fr) 2012-10-04
WO2012134170A3 true WO2012134170A3 (fr) 2013-01-17

Family

ID=46932122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/002279 Ceased WO2012134170A2 (fr) 2011-03-28 2012-03-28 Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia

Country Status (2)

Country Link
KR (1) KR20120109142A (fr)
WO (1) WO2012134170A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040105902A1 (en) * 2002-12-02 2004-06-03 Jiafang Chen Compositions and methods for treating prostate cancer
KR100485133B1 (ko) * 2001-12-27 2005-04-22 류종훈 천초근 추출물을 함유하는 뇌세포 보호 및 뇌졸중 치료를위한 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100485133B1 (ko) * 2001-12-27 2005-04-22 류종훈 천초근 추출물을 함유하는 뇌세포 보호 및 뇌졸중 치료를위한 조성물
US20040105902A1 (en) * 2002-12-02 2004-06-03 Jiafang Chen Compositions and methods for treating prostate cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HO-SEUNG CHOI ET AL., KOREAN JOURNAL OF ORIENTAL MEDICAL PHYSIOLOGY, vol. 22, no. 3, 2008, pages 548 - 555 *
KATSUHIRO INOUE ET AL.: "Activity of RA-700, a cyclic hexapeptide from Rubiae Radix, in the human tumor clonogenic assay", INVESTIGATION NEW DRUGS, vol. 4, no. ISS. 3, 1986, pages 231 - 236 *

Also Published As

Publication number Publication date
WO2012134170A2 (fr) 2012-10-04
KR20120109142A (ko) 2012-10-08

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
CA2900335C (fr) Analogues synthetiques d'epipolythiodioxopiperazines et leurs utilisations
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2013040395A3 (fr) Composition de soin de la peau à base d'herbes
PH12014501639B1 (en) Pharmaceutical compositions and methods
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
WO2012134169A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de semence de gleditsiae
WO2013098416A3 (fr) Composes anti-douleur
EP3067059A4 (fr) Composition pharmaceutique pour prévenir ou traiter des maladies thyroïdiennes, contenant de l'extrait de fruit de lonicera caerulea l. var. edulis comme principe actif
WO2013012197A3 (fr) Composition pour prévenir ou atténuer les rides de la peau contenant de l'extrait de honeybush ou une liqueur fermentée de celui-ci en tant que principe actif
WO2012134252A3 (fr) Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2012036414A3 (fr) Composition cosmétique comprenant une fraction d'extrait de soja fermenté au titre de principe actif
WO2012134250A3 (fr) Composition pour le traitement du cancer du rein et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena
WO2012134168A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait d'herbe de lysimachia foenum-graecum
WO2012134167A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait d'eriobotriae folium
WO2012134251A3 (fr) Composition pour le traitement du cancer du pancréas et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012134170A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia
WO2012134163A3 (fr) Composition pour le traitement du cancer du poumon et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012134165A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de semence de psoraleae
WO2012108746A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de racine de rubia cordifolia
WO2012030142A3 (fr) Composition pour traiter le cancer de la prostate comprenant un extrait de nard

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12762793

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12762793

Country of ref document: EP

Kind code of ref document: A2